Michael Sassano

large-scale cannabis infrastructure and pioneering advanced cannabinoid pharmaceuticals. Michael's reputation is built on his proven ability to successfully predict long-term market trends and guide companies strategically, an expertise he regularly shares as a writer and sought-after speaker.

Through Green Rush Partners, Michael has guided the strategic direction and execution for over 59 companies and built 27 facilities across the United States and now Europe. Michael's comprehensive approach was exemplified by the creation of Solaris Farms. Under his direction, the venture was built from a bare lot of land into one of Nevada’s largest and most respected double-vertically-integrated cannabis companies, through a successful merger. This project stands as a testament to Michael's capability in building significant infrastructure and market value.

In recent years, Michael has directed Green Rush Partners’ focus towards the European Union and emerging global markets. The firm's flagship international initiative is the development of Somai Pharmaceuticals, now a leading EU-GMP vertically integrated company. Leveraging the product and market knowledge honed in the competitive U.S. landscape, he has established Somai as one of a few fully vertically integrated multi-country operators in Europe.

As Interim CEO and Chairman GR of Somai, Michael demonstrates the Green Rush Partners philosophy: bringing together world-class scientific teams to guide product development and create transformative treatments for the endocannabinoid system. His primary goal is to produce the most advanced products with innovative delivery methods that maximize bioavailability and patient outcomes. Somai’s extensive IP portfolio and pipeline of proprietary products position it as a key biotech player for the next decade.

You can read his analysis and industry commentary at: https://www.somaipharma.eu/news